AstraZeneca and Gilead Science to merge?
How likely is deal?
Bloomberg reported that AstraZeneca contacted Gilead last month about a potential $232 bln pharma powerhouse merger. According to Jefferie analysts the merger is unlikely:
Skip to content
Leave a Comment